Stealth BioTherapeutics Competitors and Similar CompaniesClear all
Stealth BioTherapeutics's competitors and similar companies include Oxford BioTherapeutics, Orchard Therapeutics and Cogent Biosciences.
 Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders. |  Cogent Biosciences Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2004 | Founding Date 2015 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Newton, US HQ Needham, US | Locations Milton, GB HQ San Jose, US | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Waltham, US HQ Boulder, US |
Employees | Employees 592% decrease | Employees 512% increase | Employees 166 | Employees 16419% increase |
Valuation ($) | Valuation ($) 18.4 m | Valuation ($) N/A | Valuation ($) 380.1 m | Valuation ($) 1.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £2.1m (FY, 2018) | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income ($52.5m) (FY, 2021) | Net income (£6.5m) (FY, 2018) | Net income ($150.7m) (FY, 2022) | Net income ($192.4m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 21.6m | Total funding raised $ 310.7m | Total funding raised $ 178.3m |
For sources of this data, please see the company profile
View Company Profiles
Oxford BioTherapeutics
HQ
Milton, GB
Employees
51↑ 2% increase
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View companyOrchard Therapeutics
HQ
London, GB
Employees
166
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
View companyCogent Biosciences
HQ
Waltham, US
Employees
164↑ 19% increase
Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases.
View company